The different impact of drug-resistant Leishmania on the transcription programs activated in neutrophils.
Details
Download: 38711445_BIB_5116AC3E7FBF.pdf (5093.62 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_5116AC3E7FBF
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
The different impact of drug-resistant Leishmania on the transcription programs activated in neutrophils.
Journal
iScience
ISSN
2589-0042 (Electronic)
ISSN-L
2589-0042
Publication state
Published
Issued date
17/05/2024
Peer-reviewed
Oui
Volume
27
Number
5
Pages
109773
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Abstract
Drug resistance threatens the effective control of infections, including parasitic diseases such as leishmaniases. Neutrophils are essential players in antimicrobial control, but their role in drug-resistant infections is poorly understood. Here, we evaluated human neutrophil response to clinical parasite strains having distinct natural drug susceptibility. We found that Leishmania antimony drug resistance significantly altered the expression of neutrophil genes, some of them transcribed by specific neutrophil subsets. Infection with drug-resistant parasites increased the expression of detoxification pathways and reduced the production of cytokines. Among these, the chemokine CCL3 was predominantly impacted, which resulted in an impaired ability of neutrophils to attract myeloid cells. Moreover, decreased myeloid recruitment when CCL3 levels are reduced was confirmed by blocking CCL3 in a mouse model. Collectively, these findings reveal that the interplay between naturally drug-resistant parasites and neutrophils modulates the infected skin immune microenvironment, revealing a key role of neutrophils in drug resistance.
Keywords
Immunology, Parasitology
Pubmed
Web of science
Open Access
Yes
Create date
10/05/2024 14:32
Last modification date
09/08/2024 14:59